Friday, October 13, 2017 7:16:47 AM
REUTERS 6:10 AM ET 10/13/2017
Symbol Last Price Change
RVXCF 1.4184up 0 (0%)
QUOTES AS OF 02:52:01 PM ET 10/12/2017
Oct 13 (Reuters) - Shenzhen Hepalink Pharmaceutical Co Ltd
* Says it plans to invest up to C$87 million ($69.75 million) in Canada'sResverlogix Corp(RVXCF)
Source text in Chinese: http://bit.ly/2i9ZrGw
Further company coverage: ($1 = 1.2473 Canadian dollars) (Reporting by Hong Kong newsroom)
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM